Time Course-dependent Evolution of Nitric Oxide-mediated Arterial Hyporeactivity to Phenylephrine in Rats with Ligated Bile Duct

References

• Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983; 244:G52–7.
   Google Scholar
• Sharpiro MD, Nicholls KM, Groves BM, Kluge R, Chung H-M, Bichet DG, et al. Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients. Kidney Int 1985;28:206–11.
   Google Scholar
• Vorobioff J, Bredfeldt JE, Groszmann RJ. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology 1984;87:1120–6.
   Google Scholar
• Bomzon A, Blendis LM. Vascular reaktivity in experimental portal hypertension. Am J Physiol 1987;252:G158.
   PubMed Web of Science ®Google Scholar
• Kiel JW, Pitts V, Benoit jN, Granger DN, Shepherd AP. Reduced vascular sensitivity to norepinephrine in portal hypertensive rats. Am J Physiol 1985;248:G192–5.
   Google Scholar
• Michielsen PP, Boeckxstaens GE, Sys SU, Herman AG, Pelckmans PA. Role of nitric oxide in hyporeactivity to noradrenaline of isolated aortic rings in portal hypertensive rats. Eur J Pharmacol 1995;273:167–74.
   Google Scholar
• Pizcueta MP, Casamitjana R, Bosch J, Rodés J. Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism. Am J Physiol 1990;258: G191–5.
   Google Scholar
• Sieber CC, Groszmann RJ. In vitro hyporeactivity to methox-amine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Physiol 1992;262:G996–1001.
   PubMedGoogle Scholar
• Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenterc vessels of portal hypertensive rats. Gastroenterology 1992;103:235–9.
   PubMed Web of Science ®Google Scholar
• Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993;104:1750–4.
   PubMed Web of Science ®Google Scholar
• Albornoz L, Bandi JC, Sanchez S, Spinedi E, Canteros G, De Paula JA, et al. Role of nitric oxide alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension [abstract]. Med BA 1994;54:17–24.
   Google Scholar
• Clària J, Jiménez W, Ros J, Asbert M, Castro A, Arroyo V, et al. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 1992;15: 343–9.
   PubMed Web of Science ®Google Scholar
• Iwata F, Joh T, Kawai T, Itoh M. Role of EDRF in spplanchnic blood flow of normal and chronic portal hypertensive rats. Am J Physiol 1992;263:G149–54.
   Google Scholar
• Niederberger M, Ginés P, Tsai P, Martin P-Y, Morris K, Weigert A, et al. Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilatation in cirrhosis. Hepatology 1995;21:1625–31.
   PubMed Web of Science ®Google Scholar
• Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524–6.
   Google Scholar
• Fineman JR, Heyman MA, Soifer SJ. N^-nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilatation in lambs. Am J Physiol 1991;260:H1299–306.
   Google Scholar
• Ishii K, Chang B, Kerwin JF, Huang ZJ, Murad F. N^-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol 1990;176:219–23.
   Google Scholar
• Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373–6.
   PubMed Web of Science ®Google Scholar
• Sachs L Angewandte Statistik. Berlin: Springer; 1992;Chapter 422.
   Google Scholar
• Dunn OJ. Multiple comparisons using rank sums. Technometrics 1964;6:241–52.
   Web of Science ®Google Scholar
• Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952;47:583–621 and 1953;48: 907–11.
   Google Scholar
• Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiological messenger. Ann Intern Med 1994;120:227–37.
   Google Scholar
• Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991;337:776–8.
   PubMed Web of Science ®Google Scholar
• Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988;8:232–6.
   Google Scholar
• Laffi G, Foschi M, Masini E, Simoni A, La Villa G, Barletta G, et al. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology 1995;22:1666–73.
   PubMed Web of Science ®Google Scholar
• Niederberger M, Martin PY, Ginés P, Morris K, Tsai P, Xu DL, et al. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology 1995;109:1624–30.
   Google Scholar
• Castro A, Jiménez W, Clària J, Ros J, Martínez JM, Bosch M, et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology 1993;18:367–72.
   PubMed Web of Science ®Google Scholar
• Clària J, Jiménez W, Ros J, Rigol M, Angeli P, Arroyo V, et al. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology 1994;20:1615–21.
   PubMed Web of Science ®Google Scholar
• Pizcueta MP, Piqué JM, Fernandez M, Bosch J, Rodés J, Whittle BJ, et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992;103: 1909–15.
   PubMed Web of Science ®Google Scholar
• Fernández M, Garciá-Pagán JC, Casadevall M, Bernadich C, Piera C, Whittle BJR, et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portalhypertensive rats. Gastroenterology 1995;108:1487–95.
   PubMed Web of Science ®Google Scholar
• Sogni P, Moreau M, Cailmail S, Oberti F, Hadengue A, Pussard E, et al. Evidence for normal nitric oxide mediated vasodilator tone in conscious rats with cirrhosis. Hepatology 1992;16:980–3.
   PubMedGoogle Scholar
• Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151–7.
   Google Scholar
• Fernández-Muhoz D, Caramelo C, Santos JC, Blanchart A, Hernando L, López-Novoa JM. Systemic and splanchnic hemodynamic disturbances in conscious rats with experimental liver cirrhosis without ascites. Am J Physiol 1985;249:G316–20.
   Google Scholar
• Bomzon A, Rosenberg M, Gali D, Binah O, Mordechovitz D, Better OS, et al. Systemic hypotension and decreased pressor response in dogs with chronic bile duct ligation. Hepatology 1986;6:595–600.
   PubMedGoogle Scholar
• Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984;65:305–11.
   Google Scholar
• Weigert AL, Martin P-Y, Niederberger M, Higa EMS, McMurty IF, Ginès P, et al. Endothelium-dependent vascular hyporespon-siveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats. Hepatology 1995;22:1856–62.
   Google Scholar
• Niederberger M, Ginès P, Martin P-Y, Tsai P, Morris K, McMurty I, et al. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhotis versus prehepatic portal hypertension in rats. Hepatology 1996;24:947–51.
   PubMedGoogle Scholar
• Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993;18:1139–43.
   PubMed Web of Science ®Google Scholar
• Morales-Ruiz M, Jiminez W, Pérez-Sala D, Ros J, Leivas A, Lamas S, et al. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 1996; 24:1481–6.
   Google Scholar
• Diez-Ruiz A, Tilz GP, Gutierrez-Gea F, Gil-Extremera B, Murr C, Wachter H, et al. Neopterin and soluble tumor necrosis factor receptor type I in alcohol-induced cirrhosis. Hepatology 1995; 21:976–8.
   Google Scholar
• Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264–74.
   PubMed Web of Science ®Google Scholar
• Lopez-Talavera JC, Cadelina G, Olchowski J, Merrili W, Groszmann RJ. Thalidomide inhibits tumor necrosis factor α, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal hypertensive rats. Hepatology 1996;23:1616–21.
   Google Scholar